Rush University Medical Center. is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Rush University Medical Center. has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: HER2-positive Breast Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rush University Medical Center. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush University Medical Center. has 1 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer.
Rush University Medical Center. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.